iBio
IBIO
#10391
Rank
A$67.71 M
Marketcap
A$1.36
Share price
9.06%
Change (1 day)
9.36%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): A-$1.17

According to iBio's latest financial reports the company's current EPS (TTM) is A-$1.08. In 2025 the company made an earnings per share (EPS) of A-$2.51 an increase over its 2024 EPS that were of A-$9.33.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.17-53.31%
2025A-$2.51-73.08%
2024A-$9.33-93.88%
2023A-$152.38-8.14%
2022A-$165.8992.67%
2021A-$86.10-80.33%
2020A-$437.67-35.11%
2019A-$674.45-38.96%
2018A-$1,105-6.1%
2017A-$1,17736.67%
2016A-$861.0033.33%
2015A-$645.7550%
2014A-$430.50-53.85%
2013A-$932.75-7.14%
2012A-$1,004-64.1%
2011A-$2,79877.27%
2010A-$1,578144.44%
2009A-$645.7512.93%
2008A-$571.8312.2%
2007A-$509.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.53-1,264.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
A-$0.75-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$9.61 793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$4.94 358.67%๐Ÿ‡บ๐Ÿ‡ธ USA